238 related articles for article (PubMed ID: 37834120)
1. Estrogens, Estrogen Receptors and Tumor Microenvironment in Ovarian Cancer.
Kozieł MJ; Piastowska-Ciesielska AW
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834120
[TBL] [Abstract][Full Text] [Related]
2. The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication.
De Nola R; Menga A; Castegna A; Loizzi V; Ranieri G; Cicinelli E; Cormio G
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096567
[TBL] [Abstract][Full Text] [Related]
3. Estrogens and epithelial ovarian cancer.
Cunat S; Hoffmann P; Pujol P
Gynecol Oncol; 2004 Jul; 94(1):25-32. PubMed ID: 15262115
[TBL] [Abstract][Full Text] [Related]
4. Effect of steroid hormones, estrogen and progesterone, on epithelial mesenchymal transition in ovarian cancer development.
Jeon SY; Hwang KA; Choi KC
J Steroid Biochem Mol Biol; 2016 Apr; 158():1-8. PubMed ID: 26873134
[TBL] [Abstract][Full Text] [Related]
5. The epithelial-mesenchymal transition and the estrogen-signaling in ovarian cancer.
Gallo D; Ferlini C; Scambia G
Curr Drug Targets; 2010 Apr; 11(4):474-81. PubMed ID: 20015012
[TBL] [Abstract][Full Text] [Related]
6. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
Rochefort H
C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
[TBL] [Abstract][Full Text] [Related]
7. The Role of the Estrogen Pathway in the Tumor Microenvironment.
Rothenberger NJ; Somasundaram A; Stabile LP
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463044
[TBL] [Abstract][Full Text] [Related]
8. Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer.
Benhadjeba S; Edjekouane L; Sauvé K; Carmona E; Tremblay A
Mol Oncol; 2018 Oct; 12(10):1689-1705. PubMed ID: 30051594
[TBL] [Abstract][Full Text] [Related]
9. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
Kim YS; Choi KC; Hwang KA
Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment with the pure anti-estrogen fulvestrant durably remodels estrogen signaling in BG-1 ovarian cancer cells.
Badia E; Docquier A; Busson M; Lapierre M; Pujol P; Balaguer P; Cavailles V
J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):176-85. PubMed ID: 22652558
[TBL] [Abstract][Full Text] [Related]
11. New insights on the role of hormonal therapy in ovarian cancer.
Simpkins F; Garcia-Soto A; Slingerland J
Steroids; 2013 Jun; 78(6):530-7. PubMed ID: 23402742
[TBL] [Abstract][Full Text] [Related]
12. Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers.
Ciucci A; Zannoni GF; Buttarelli M; Lisi L; Travaglia D; Martinelli E; Scambia G; Gallo D
Oncotarget; 2016 Feb; 7(7):8155-71. PubMed ID: 26797759
[TBL] [Abstract][Full Text] [Related]
13. The Cell-Free Expression of MiR200 Family Members Correlates with Estrogen Sensitivity in Human Epithelial Ovarian Cells.
Márton É; Varga A; Széles L; Göczi L; Penyige A; Nagy B; Szilágyi M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419253
[TBL] [Abstract][Full Text] [Related]
14. Effect of benzophenone-1 and octylphenol on the regulation of epithelial-mesenchymal transition via an estrogen receptor-dependent pathway in estrogen receptor expressing ovarian cancer cells.
Shin S; Go RE; Kim CW; Hwang KA; Nam KH; Choi KC
Food Chem Toxicol; 2016 Jul; 93():58-65. PubMed ID: 27145024
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
Carruba G
J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
[TBL] [Abstract][Full Text] [Related]
16. The action of estrogens and progestogens in the young female breast.
Zolfaroli I; Tarín JJ; Cano A
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():204-207. PubMed ID: 29627127
[TBL] [Abstract][Full Text] [Related]
17. Non-genomic estrogen/estrogen receptor α promotes cellular malignancy of immature ovarian teratoma in vitro.
Hung YC; Chang WC; Chen LM; Chang YY; Wu LY; Chung WM; Lin TY; Chen LC; Ma WL
J Cell Physiol; 2014 Jun; 229(6):752-61. PubMed ID: 24142535
[TBL] [Abstract][Full Text] [Related]
18. Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogen and Its Receptors in Cancer Physiopathology.
Segovia-Mendoza M; Morales-Montor J
Front Immunol; 2019; 10():348. PubMed ID: 30881360
[TBL] [Abstract][Full Text] [Related]
19. [A hormonal impact on DMBA-induced rat ovarian cancer--detection of estrogen receptors, and resultant morphologic changes after estrogen application].
Katabuchi H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1634-40. PubMed ID: 6413623
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of androgen receptor coactivator p44/Mep50/WDR77 in ovarian cancer.
Ligr M; Patwa RR; Daniels G; Pan L; Wu X; Li Y; Tian L; Wang Z; Xu R; Wu J; Chen F; Liu J; Wei JJ; Lee P
PLoS One; 2011; 6(10):e26250. PubMed ID: 22022581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
